InsidersTradesSigma
Follow the 씨어스 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 씨어스 has published 14 public disclosures. Market capitalisation: €858.2bn. The latest transaction was disclosed on 1 April 2026 (Purchase). Among the most active insiders: 윈베스트벤처투자. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
14 of 14 declarations
씨어스 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and commercialization of pharmaceutical products.